<- Go Home
Atrys Health, S.A.
Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic counselling; and diagnostic reports and genetic tests. It also provides telemedicine services, such as teleradiology, telecardiology, teleoncology, teledermatology, teleophthalmology, and teleconsultations; prevention plans for companies, which includes training plans on occupational risk prevention; Smart Data, a technological database for healthcare; and research and development services. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.
Market Cap
EUR 214.1M
Volume
66.9K
Cash and Equivalents
EUR 13.1M
EBITDA
EUR 6.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 24.9M
Profit Margin
17.27%
52 Week High
EUR 3.59
52 Week Low
EUR 2.48
Dividend
N/A
Price / Book Value
1.41
Price / Earnings
-3.86
Price / Tangible Book Value
-4.25
Enterprise Value
EUR 458.4M
Enterprise Value / EBITDA
40.08
Operating Income
-EUR 10.4M
Return on Equity
27.46%
Return on Assets
-1.21
Cash and Short Term Investments
EUR 13.6M
Debt
EUR 257.9M
Equity
EUR 152.0M
Revenue
EUR 144.3M
Unlevered FCF
-EUR 117.6M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium